← FDA DRUG APPROVALS

FDA ANDA · ANDA207957

WELBY FLUTICASONE

fluticasone propionate

Sponsor: HIKMA

APPLICATION
ANDA207957
TYPE
ANDA
ORIGINAL APPROVAL
2016-05-26
LATEST ACTION
2019-11-27
ROUTE
NASAL
DOSAGE FORM
SPRAY, METERED
MARKETING STATUS
Over-the-counter

Products

FLUTICASONE PROPIONATEOver-the-counter
FLUTICASONE PROPIONATE 0.05MG/SPRAY · SPRAY, METERED · NASAL

Approval history

2019-11-27Labeling · Supplement 4 · standardAP
2016-12-29Manufacturing (CMC) · Supplement 2 · unknownAP
2016-08-02Manufacturing (CMC) · Supplement 1 · unknownAP
2016-05-26UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →